ASX ANNOUNCEMENT 20 October 2026 Unmarketable Parcel Sale Facility Cynata Therapeutics Limited (Cynata or the Company) (ASX: CYP) is pleased to announce that it has established a Share Sale Facility for holders of Unmarketable Parcels of shares in the Company (Facility). An ‘Unmarketable...
Unmarketable Parcel Sale Facility
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Notification of buy-back - CYP
- Letter to Ineligible Shareholders-Entitlement Offer
- Letter to Eligible Shareholders-Entitlement Offer
- Replacement Target Market Determination
- Replacement Prospectus
Later from Cynata Therapeutics
- Paul Wotton to Resign as Director from AGM
- Letter to Shareholders, Notice of AGM & Proxy Form
- September 2026 Quarterly Activity Report & Appendix 4C
- Results of Fully Underwritten Entitlement Offer
- Consultancy Agreement
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics